In 2008, it was approved for the treatment of both indolent and aggressive B cell NHL after it was found to successfully treat NHL that had relapsed after primary treatment with rituximab or a rituximab containing regimen in three independent phase II trials 133, 134
propecia timeline Hematologists are often asked to advise on the risks of hormonal therapy or pregnancy in a woman with a personal or family history of thrombosis or with an abnormal laboratory finding
